BMAP-27
General Information
DRACP ID DRACP03506
Peptide Name BMAP-27
Sequence GRFKRFRKKFKKLFKKLSPVIPLLHL
Sequence Length 26
UniProt ID B9UKM4 B9UKM3 P54228
PubChem CID Not available
Origin Animalia
Type Native peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C158H262N44O28
Absent amino acids ACDEMNQTWY
Common amino acids K
Mass 367218
Pl 12.84
Basic residues 11
Acidic residues 0
Hydrophobic residues 11
Net charge 11
Boman Index -4525
Hydrophobicity -36.54
Aliphatic Index 101.15
Half Life
Mammalian: 30 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 2
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 31226350
Title Structural analysis and mode of action of BMAP-27, a cathelicidin-derived antimicrobial peptide
Doi Not available
Year 2019
Literature 2
Pubmed ID 29882774
Title Influence of Bacterial Biofilm Polysaccharide Structure on Interactions with Antimicrobial Peptides: A Study on Klebsiella pneumoniae
Doi Not available
Year 2018
Literature 3
Pubmed ID 19845398
Title Design of nontoxic analogues of cathelicidin-derived bovine antimicrobial peptide BMAP-27: the role of leucine as well as phenylalanine zipper sequences in determining its toxicity
Doi Not available
Year 2009
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID 5973